Related Experiment Video
Updated: Jul 30, 2026

11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
The search for level I evidence in solid-tumor oncology
A D Brooks1, H M Karpoff, I Sulimanoff
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Annals of Surgical Oncology
|September 25, 2001
Summary
A new method efficiently identifies and filters high-quality evidence for solid tumor oncology. This tool provides clinicians with portable access to crucial therapeutic data, enhancing medical decision-making.
Area of Science:
- Oncology
- Medical Informatics
Background:
- Developing a systematic approach to identify and disseminate Level I evidence in solid tumor oncology.
- Addressing the challenge of accessing high-quality therapeutic trial data for clinicians.
Purpose of the Study:
- To create a robust method for filtering, reviewing, and distributing Level I evidence in solid tumor oncology.
- To enhance the accessibility and utility of critical research findings for oncologists.
Main Methods:
- Conducted standardized MEDLINE searches for prospective randomized controlled trials (PRCTs) in solid tumor oncology with therapeutic endpoints.
- Reviewed all identified PRCTs with surgical oncology fellows and experts, importing data into a comprehensive database.
- Tabulated statistical methods per Consolidated Standard of Reporting Trials (CONSORT) guidelines and included reviewer comments, assigning a Level Ia designation to high-quality studies.
Main Results:
- PRCTs concerning solid organ malignancy therapy constitute only 0.03% of MEDLINE articles.
- Approximately 14% of reviewed articles met the criteria for a Level Ia designation.
- Intranet and personal digital assistant (PDA) access to the database enhances educational value and specificity of information.
Conclusions:
- A novel tool has been developed to screen and record medical data for clinicians using a specialized filtering system.
- The system makes critical medical information accessible and portable via the Internet and PDAs, supporting evidence-based practice.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

